Krsnaa cuts Rajasthan revenue guidance by half, delays rollout
The flagship PPP project now targets ₹100-150 crore for FY27, down from ₹200-250 crore, as the network launch slips to Q2.
— 5 earlier stories on Krsnaa Diagnostics Ltd. →What's new
- Rajasthan PPP project revenue guidance for FY27 slashed to ₹100-150 cr from ₹200-250 cr.
- Rollout of 27 mother labs and 800 collection centers delayed to Q2 FY27.
- Days sales outstanding stuck at 139 days, above the 120-day target.
Why this matters
The guidance cut halves the expected FY27 contribution from a project central to Krsnaa's public-sector growth story. It lands just as the company reports its first-ever ₹1,000 crore net profit year.
What we're watching
- Whether the delayed Q2 FY27 Rajasthan rollout proceeds on the new schedule.
- Progress toward the retail diagnostics break-even target for FY27.
- Movement in DSO toward the 120-day target, a critical cash-flow metric.
The full read
Krsnaa just logged its first ₹1,000 crore profit year. It also cut in half the revenue outlook for the project meant to fund the next phase. The Rajasthan PPP project now targets ₹100-150 crore for FY27, down from a ₹200-250 crore aspiration. The reason is a six-month delay in rolling out 27 mother labs and 800 collection centers. That rollout was supposed to be complete by Q4 FY26. Now it's a Q2 FY27 event. Meanwhile, the company is deploying a ₹500 crore capex plan and retail diagnostics grew sixfold to ₹60 crore. But 139 days of receivables remain stuck above the 120-day target. Management speaks of a ₹6,000-7,000 crore opportunity over five to seven years. The immediate problem is simpler. The FY27 bridge to that future just got cut in width.
Questions answered
- Why was the Rajasthan revenue guidance cut so sharply?
- The physical rollout of the lab network slipped from Q4 FY26 to Q2 FY27. That six-month delay compresses the revenue-earning period within the financial year.
- What is the new guidance figure for the Rajasthan project?
- Management now targets ₹100-150 crore in revenue for FY27, down from the prior aspiration of ₹200-250 crore.
- How does this delay affect the overall business outlook?
- The company still reported record profitability and saw retail diagnostics revenue jump sixfold. However, the Rajasthan project was a core growth driver, and its reduced guidance will weigh on FY27 revenue growth.
- What is the status of the company's receivables?
- Days sales outstanding remained at 139 days, missing the internal target of 120 days. This persistent gap ties up working capital.
Krsnaa Diagnostics Ltd.
Latest quarter · Dec 2025
Strength & growth
Story so far
All notes on KRSNAA →- 26 May 2026 · 1:53 PM IST Krsnaa cuts Rajasthan revenue guidance by half, delays rollout
- 41d ago Krsnaa Diagnostics releases Q4 and FY26 management commentary
- 42d ago Krsnaa Diagnostics reports FY26 results with no new surprises
- 42d ago Krsnaa Diagnostics posts FY26 profit of ₹102.7 cr but the numbers are stale
- 42d ago Krsnaa's profit is up 24% but it's hiding a ₹63 crore tax demand.